Keerthi Gogineni, MD, MSHP
-
RoleMedical Oncology
-
Specialty
-
Research Program
-
Practicing Since2010
Background
Keerthi Gogineni, MD joined the Glenn Family Breast Center as Associate Professor in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University in February 2015, where she sees patients with breast malignancies and actively collaborates with other Winship members in clinical trials and health policy research. Dr. Gogineni is dual board-certified in Hematology and Medical Oncology.
After completion of her fellowship training, she was appointed to the Division of Hematology-Oncology at the Hospital of the University of Pennsylvania in 2010, where she specialized in the evaluation and treatment of patients with breast malignancies. As a breast oncologist, she expertly guided patients through a complex maze of treatment options and explained potentially debilitating effects of disease and treatment. She also taught residents and fellows about fundamental principles of breast cancer management and lectured them on health policy issues affecting oncology.
Dr. Gogineni graduated with honors in 1999 from Brown University in Providence, Rhode Island, where she received the George W. Hagy Prize for Distinction in Human Biology. After graduation, she worked in Washington, DC as a public policy fellow at AIDS Action, a non-profit organization representing AIDS service organizations on Capitol Hill. She went on to graduate from the University of Maryland School of Medicine in Baltimore, Maryland, in 2004. After medical school, she completed her residency training in Internal Medicine in 2007 and her fellowship training in Hematology-Oncology at the Hospital of the University of Pennsylvania in Philadelphia in 2010. She completed a Masters of Science in Health Policy Research at the Perelman School of Medicine at the University of Pennsylvania in 2011.
Titles & Roles
-
Associate Professor, Department of Hematology and Medical OncologyEmory University School of Medicine
-
Director for Education of Fellows and Residents Grady Health SystemGrady Health System
-
Associate Director, Hematology and Medical Oncology Fellowship ProgramEmory University School of Medicine
-
Co-Vice Chair of Diversity, Equity, and Inclusion, Department of Hematology and Medical OncologyEmory University School of Medicine
Education & Training
Education
- Professional Education, , 2011University of Pennsylvania
- Fellowship, Hematology & Oncology, 2010Hospital of the University of Pennsylvania
- Internship, Internal Medicine, 2007Hospital of the University of Pennsylvania
- Medical Education, , 2004University of Maryland School of Medicine
Board Certifications
- Medical OncologyAmerican Board of Internal Medicine, 2010HematologyAmerican Board of Internal Medicine, 2010
-
-
PhaseI/II
-
ConditionsBreast Cancer, Metastatic Breast Cancer
-
LocationWinship Cancer Institute
-
Title/Journal Authors Publication Date JCO precision oncology
CJ Calfa, M Rothe, PK Mangat, E Garrett-Mayer, ER Ahn, ML Burness, K Gogineni, N Rohatgi, T Al Baghdadi, A Conlin, A Gaba, O Hamid, J Krishnamurthy, NJ Gavini, PJ Gold, J Rodon, J Rueter, R Thota, GN Grantham, DC Hinshaw, A Gregory, S Halabi, RL Schilsky 01/02/2024 Cancer medicine
S Awan, G Saini, K Gogineni, JM Luningham, LJ Collin, S Bhattarai, R Aneja, CP Williams 01/08/2023 Frontiers in oncology
JM Miller-Kleinhenz, L Moubadder, KM Beyer, Y Zhou, AH Gaglioti, LJ Collin, J Gohar, W Do, K Conneely, U Krishnamurti, K Gogineni, S Gabram-Mendola, O D'Angelo, K Henry, M Torres, LE McCullough 01/01/2023 Cancer causes & control : CCC
A Balenger, G Seth, S Bhattarai, LJ Collin, L McCullough, K Gogineni, P Subhedar, C Ellison, U Khan, MH Swahn, R Aneja 01/12/2022 Cardiovascular and interventional radiology
R Wu, K Gogineni, J Meisel, S Szabo, M Thirunavu, S Friend, Z Bercu, I Sethi, N Natarajan, J Switchenko, J Levy, E Abdalla, L Weakland, K Kalinsky, N Kokabi 01/11/2022 JAMA network open
JM Luningham, G Seth, G Saini, S Bhattarai, S Awan, LJ Collin, MH Swahn, D Dai, K Gogineni, P Subhedar, P Mishra, R Aneja 03/10/2022 Bioinformatics (Oxford, England)
H Duanmu, S Bhattarai, H Li, Z Shi, F Wang, G Teodoro, K Gogineni, P Subhedar, U Kiraz, EAM Janssen, R Aneja, J Kong 30/09/2022 Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality.
Cancer
L Moubadder, LJ Collin, R Nash, JM Switchenko, JM Miller-Kleinhenz, K Gogineni, KC Ward, LE McCullough 15/09/2022 JCO oncology practice
K Gogineni, K Kalinsky 01/04/2022 Journal of cancer education : the official journal of the American Association for Cancer Education
KA Yeager, J Bai, K Gogineni, JL Meisel, J Kweon, DW Bruner, D Waldrop-Valverde 01/04/2022 Breast cancer research and treatment
J Gohar, WL Do, J Miller-Kleinhenz, K Conneely, U Krishnamurti, O D'Angelo, K Gogineni, M Torres, S Gabram-Mendola, LE McCullough 01/02/2022 Journal of the National Comprehensive Cancer Network : JNCCN
LJ Collin, M Yan, R Jiang, K Gogineni, P Subhedar, KC Ward, JM Switchenko, J Lipscomb, J Miller-Kleinhenz, MA Torres, J Lin, LE McCullough 16/08/2021 Breast cancer research and treatment
G Saini, K Gogineni, RA Kittles, R Aneja 01/06/2021 Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer.
Cancers
ML Maliniak, J Miller-Kleinhenz, DP Cronin-Fenton, TL Lash, K Gogineni, EAM Janssen, LE McCullough 06/05/2021 Quadruple-negative breast cancer: novel implications for a new disease.
Breast cancer research : BCR
S Bhattarai, G Saini, K Gogineni, R Aneja 19/11/2020 Journal of cancer education : the official journal of the American Association for Cancer Education
BA McDaniels, RS Hianik, C Bellcross, WL Shaib, J Switchenko, MD Dixon, JL Meisel, K Gogineni, RD Pentz 01/10/2020 Breast cancer research : BCR
ML Maliniak, AM Cheriyan, ME Sherman, Y Liu, K Gogineni, J Liu, J He, U Krishnamurti, J Miller-Kleinhenz, R Ashiqueali, J He, R Yacoub, LE McCullough 17/06/2020 Clinical cancer research : an official journal of the American Association for Cancer Research
K Mittal, MS Toss, G Wei, J Kaur, DH Choi, BD Melton, RM Osan, IM Miligy, AR Green, EAM Janssen, H Søiland, K Gogineni, U Manne, P Rida, EA Rakha, R Aneja 15/06/2020 Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
Breast cancer research and treatment
WL Do, K Conneely, S Gabram-Mendola, U Krishnamurti, O D'Angelo, J Miller-Kleinhenz, K Gogineni, M Torres, LE McCullough 01/05/2020 Annals of cancer epidemiology
LJ Collin, AN Troeschel, Y Liu, K Gogineni, K Borger, KC Ward, LE McCullough 01/03/2020 Journal of the National Cancer Institute
MA Torres, K Gogineni, DH Howard 01/03/2020 Quadruple-Negative Breast Cancer: An Uneven Playing Field.
JCO global oncology
G Saini, S Bhattarai, K Gogineni, R Aneja 01/02/2020 PloS one
KN Lee, MA Torres, AN Troeschel, J He, K Gogineni, LE McCullough 01/01/2020 Therapeutic advances in medical oncology
AI Abousaud, MS Barbee, CC Davis, SE Caulfield, Z Wang, A Boykin, BC Carthon, K Gogineni 01/01/2020 International journal of epidemiology
AN Troeschel, Y Liu, LJ Collin, PT Bradshaw, KC Ward, K Gogineni, LE McCullough 01/12/2019 Panoptic View of Prognostic Models for Personalized Breast Cancer Management.
Cancers
G Saini, K Mittal, P Rida, EAM Janssen, K Gogineni, R Aneja 07/09/2019 JNCI cancer spectrum
LJ Collin, R Jiang, KC Ward, K Gogineni, PD Subhedar, ME Sherman, MM Gaudet, CR Breitkopf, O D'Angelo, S Gabram-Mendola, R Aneja, AH Gaglioti, LE McCullough 01/09/2019 Clinical breast cancer
E Paplomata, A Zelnak, CA Santa-Maria, Y Liu, K Gogineni, X Li, CS Moreno, Z Chen, V Kaklamani, RM O'Regan 01/06/2019 Obesity and cancer treatment efficacy: Existing challenges and opportunities.
Cancer
KH Ross, K Gogineni, PD Subhedar, JY Lin, LE McCullough 15/05/2019 Journal of oncology practice
JM Regnante, NA Richie, L Fashoyin-Aje, M Vichnin, M Ford, UB Roy, K Turner, LL Hall, E Gonzalez, N Esnaola, LT Clark, HC Adams, OB Alese, K Gogineni, L McNeill, D Petereit, I Sargeant, J Dang, C Obasaju, Q Highsmith, SC Lee, SC Hoover, EL Williams, MS Chen 01/04/2019 NPJ breast cancer
LJ Collin, M Yan, R Jiang, KC Ward, B Crawford, MA Torres, K Gogineni, PD Subhedar, S Puvanesarajah, MM Gaudet, LE McCullough 01/01/2019 Breast cancer : basic and clinical research
SB Zeichner, RL Zeichner, K Gogineni, S Shatil, O Ioachimescu 01/01/2017 Ductal carcinoma in situ: How much is too much?
Cancer
K Gogineni 15/09/2016 Oncotarget
WM Strauss, C Carter, J Simmons, E Klem, N Goodman, B Vahidi, J Romero, M Masterman-Smith, R O'Regan, K Gogineni, L Schwartzberg, LK Austin, PW Dempsey, M Cristofanilli 03/05/2016 A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
Breast cancer : basic and clinical research
SB Zeichner, H Terawaki, K Gogineni 01/01/2016 Breast cancer research and treatment
NH Lester-Coll, JM Lee, K Gogineni, WT Hwang, JS Schwartz, RG Prosnitz 01/07/2015 The Demanding Patient Revisited--Reply.
JAMA oncology
K Gogineni, KL Shuman, NB Gabler, EJ Emanuel 01/07/2015 Patient Demands and Requests for Cancer Tests and Treatments.
JAMA oncology
K Gogineni, KL Shuman, D Chinn, NB Gabler, EJ Emanuel 01/04/2015 Awards
Dr. Gogineni was awarded a Young Investigator Award from the American Society of Clinical Oncology and a Pfizer Research Fellowship in Bioethics for her research. As a fellow at the University of Pennsylvania, she received the Hematology-Oncology Jane Alavi Award for Clinical Excellence from the Department of Medicine.Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.9 Provider showed concern 4.9 Provider explained things clearly 4.9 Provider discussed treatment options 4.9 Provider included you in decisions 4.9 Likelihood of recommending this provider